Figure 2
From: Obesity paradox as a new insight from postoperative complications in gastric cancer
Overall survival curves according to the combination of PAIC and obesity status. In 499 consecutive patients with pStage II–III GC, there was a large and significant prognostic difference between non-PAIC and PAIC obese patients (P = 0.006; 5-year overall survival: 69.7% vs. 43.8%), related to the higher incidence of peritoneal recurrence in PAIC obese patients (P = 0.035; 31.2% vs. 9.5%). In contrast, there was a small prognostic difference between non-PAIC and PAIC non-obese patients (P = 0.102; 5-year overall survival: 56.5% vs. 51.9%).
